IRON
Price
$64.51
Change
+$0.90 (+1.41%)
Updated
Oct 2 closing price
Capitalization
2.49B
33 days until earnings call
Intraday BUY SELL Signals
OKYO
Price
$1.47
Change
+$0.13 (+9.70%)
Updated
Oct 2 closing price
Capitalization
71.9M
60 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IRON vs OKYO

IRON vs OKYO Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IRON vs. OKYO commentary
Oct 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRON is a Hold and OKYO is a Hold.

Interact to see
Advertisement
SUMMARIES
Loading...
FUNDAMENTALS RATINGS
IRON vs OKYO: Fundamental Ratings
IRON
OKYO
OUTLOOK RATING
1..100
6267
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
42
Fair valued
PROFIT vs RISK RATING
1..100
8259
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
7578
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
2950

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

OKYO's Valuation (42) in the null industry is in the same range as IRON (55). This means that OKYO’s stock grew similarly to IRON’s over the last 12 months.

OKYO's Profit vs Risk Rating (59) in the null industry is in the same range as IRON (82). This means that OKYO’s stock grew similarly to IRON’s over the last 12 months.

IRON's SMR Rating (97) in the null industry is in the same range as OKYO (98). This means that IRON’s stock grew similarly to OKYO’s over the last 12 months.

IRON's Price Growth Rating (75) in the null industry is in the same range as OKYO (78). This means that IRON’s stock grew similarly to OKYO’s over the last 12 months.

IRON's P/E Growth Rating (100) in the null industry is in the same range as OKYO (100). This means that IRON’s stock grew similarly to OKYO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IRONOKYO
RSI
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
69%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
76%
Bullish Trend 1 day ago
62%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
65%
Advances
ODDS (%)
Bullish Trend 15 days ago
84%
Bullish Trend 1 day ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
76%
COMPARISON
Comparison
Oct 03, 2026
Stock price -- (IRON: $64.51 vs. OKYO: $1.47)
Brand notoriety: IRON and OKYO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRON: 124% vs. OKYO: 128%
Market capitalization -- IRON: $2.49B vs. OKYO: $71.9M
IRON [@Biotechnology] is valued at $2.49B. OKYO’s [@Biotechnology] market capitalization is $71.9M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $133.74B. The average market capitalization across the [@Biotechnology] industry is $2.21B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRON’s FA Score shows that 0 FA rating(s) are green while OKYO’s FA Score has 0 green FA rating(s).

  • IRON’s FA Score: 0 green, 5 red.
  • OKYO’s FA Score: 0 green, 5 red.
According to our system of comparison, OKYO is a better buy in the long-term than IRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRON’s TA Score shows that 4 TA indicator(s) are bullish while OKYO’s TA Score has 5 bullish TA indicator(s).

  • IRON’s TA Score: 4 bullish, 6 bearish.
  • OKYO’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, OKYO is a better buy in the short-term than IRON.

Price Growth

IRON (@Biotechnology) experienced а -1.12% price change this week, while OKYO (@Biotechnology) price change was +6.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.69%. For the same industry, the average monthly price growth was -14.41%, and the average quarterly price growth was -1.73%.

Reported Earning Dates

IRON is expected to report earnings on Nov 05, 2026.

OKYO is expected to report earnings on Dec 02, 2026.

Industries' Descriptions

@Biotechnology (-3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
IRON
Daily Signal:
Gain/Loss:
OKYO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JHAI36.470.55
+1.54%
Janus Henderson Global Artificial Intelligence ETF (JHAI)
FFOG52.860.68
+1.30%
Franklin Focused Growth ETF
IMAR30.530.20
+0.65%
Innovator International Developed Power Buffer ETF March (IMAR)
IYK70.910.23
+0.33%
iShares U.S. Consumer Staples ETF (IYK)
CBTL19.93-0.03
-0.14%
Calamos Laddered Bitcoin 80 Series Structured Alt Protection ETF (CBTL)

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with NCEL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then NCEL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
+1.41%
NCEL - IRON
54%
Loosely correlated
-3.11%
AMLX - IRON
39%
Loosely correlated
-1.03%
REPL - IRON
38%
Loosely correlated
-2.83%
MLTX - IRON
38%
Loosely correlated
-0.52%
TVTX - IRON
36%
Loosely correlated
+0.14%
More